ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2301

The New Proposal Classification Criteria for Juvenile Spondyloarthropaties

Ozgur Kasapcopur1, Metin Sezen1, Kenan Barut1 and Cengizhan Acikel2, 1Pediatric Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey, 2Department of Bioistatistics, Gulhane Military Medical Academy, Ankara, Turkey

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: classification criteria, juvenile idiopathic arthritis (JIA), juvenile spondylarthropathy and spondylarthropathy

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Systemic Juvenile Idiopathic Arthritis, Spondyloarthropathy and Miscellaneous Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose

Juvenile spondyloarthropathies (JSpA) are a group of rheumatologic diseases with a disease onset before 16 years of age and are characterized with enthesitis, lower extremity oligoarthritis, involvement of the axial skeleton and HLA B27 positivity. The main problem in the classification of this group of diseases is the difficulty of diagnosis at disease onset and the difficulty to differentiate them from juvenile idiopathic arthritis. The aim of our study was to evaluate the pre-determined classification criteria for children with JSpA and to develop new classification criteria.   

Methods

The study group consisted of 113 patients with the diagnosis of JSpA and 150 patients with juvenile idiopathic arthritis (JIA). Enthesitis related arthritis (ERA) and juvenile psoriatic arthritis (JPsA) were included into the JSpA group. Eligible criterion of atypical spondyloarthropathy criteria which can also be used for children, SEA syndrome, ERA, Garmisch- Partenkirchen, ESSG, Amor, ASAS peripheral SpA, ASAS axial SpA criteria  were applied to all of the enrolled patients. Odds ratios were determined for the variables of these criteria and for clinical findings in the classification of JSpA and JIA cases. Variables of the major findings of JSpA disease were determined by using probability analysis and clinical characteristics, Specificity, sensitivity and kappa values were determined for the new set diagnostic criteria proposed by us and for the pre-determined criteria in order to evaluate which diagnostic criteria were superior for the diagnosis of JSpA.

Results

Major clinical variables of JSpA group of diseases by using pre-existing criteria are; oligoarthritis, enthesopathies, onset of disease after 6 or 10 years of age,  inflammatory lumbar pain, hip arthritis, tarsometatarsal joint arthritis,  male sex, rapid response to nonsteroidal antiinflammatory drugs, sacroiliitis  (MRI or radiography confirmed),  HLA B27 positivity, limitation in lumber mobility test (below 4 cm), family history of SpA group of disease, dactylitis, psoriasis or presence of inflammatory bowel disease. All the variables had a kappa value over 0,8. The usefullness of all of the pre-determined criteria in children was low. The variables of the new set criteria that were determined in our study were summarized below:

Major criterion: Oligoarthritis, enhesopathy, disease onset after 6 years of age, inflammatory  lumbar pain.

Minor criterion: Hip arthritis, tarsometatarsal arthrtitis,  male sex, NSAID response, sacroiliitis (in MR or radiography),  HLA B27 positivity, limitation in schober test (<4cm), family history of SpA group of disase,  dactylitis, psoriasis or presence of IBD.

Diagnosis:2 major+3 minor or 3 major variables. The sensitivity, specificity and kappa value of this criteria were found as  90.3%, 90.7%  and 0.807, respectively.

Conclusion

We found that the pre-determined criteria were inadequate for the classification and diagnosis of juvenile spondyloarthropathies. We suggest that new set criteria proposed by us could be used in the diagnosis and classification of JSpA.  However, neither the pre-determined criteria nor the new set criteria are adequate and efficacious for the classification and diagnosis of this disease.


Disclosure:

O. Kasapcopur,

Novartis Pharmaceutical Corporation,

5;

M. Sezen,
None;

K. Barut,
None;

C. Acikel,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-new-proposal-classification-criteria-for-juvenile-spondyloarthropaties/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology